Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced a global agreement to develop and commercialize ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE